Prognostic Value of Pathological Response After Conversion Therapy and Salvage Surgery in Unresectable Hepatocellular Carcinoma.
Saved in:
| Title: | Prognostic Value of Pathological Response After Conversion Therapy and Salvage Surgery in Unresectable Hepatocellular Carcinoma. |
|---|---|
| Authors: | Chi QY; Department of Hepatopancreatobiliary Surgery, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Institute of Abdominal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Clinical Research Center for Hepatobiliary Pancreatic and Gastrointestinal Malignant Tumors Precise Treatment of Fujian Province, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Fujian Provincial Key Laboratory of Precision Medicine for Cancer, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Department of Hepatopancreatobiliary Surgery, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China., Gao XD; Department of Hepatopancreatobiliary Surgery, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Institute of Abdominal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Clinical Research Center for Hepatobiliary Pancreatic and Gastrointestinal Malignant Tumors Precise Treatment of Fujian Province, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Fujian Provincial Key Laboratory of Precision Medicine for Cancer, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Department of Hepatopancreatobiliary Surgery, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China., Wang M; Department of Pathology, the First Affiliated Hospital, Fujian Medical University, Fuzhou, China., Liu QY; Department of Hepatobiliary Surgery, The Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, China., Zeng YY; Department of Hepatopancreatobiliary Surgery, Mengchao Hepatobiliary Hospital of Fujian Medical University, Fuzhou, China., Yang LF; Department of Hepatopancreatobiliary Surgery, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Institute of Abdominal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Clinical Research Center for Hepatobiliary Pancreatic and Gastrointestinal Malignant Tumors Precise Treatment of Fujian Province, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Fujian Provincial Key Laboratory of Precision Medicine for Cancer, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Department of Hepatopancreatobiliary Surgery, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China., Liu ZJ; Department of Hepatopancreatobiliary Surgery, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Institute of Abdominal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Clinical Research Center for Hepatobiliary Pancreatic and Gastrointestinal Malignant Tumors Precise Treatment of Fujian Province, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Fujian Provincial Key Laboratory of Precision Medicine for Cancer, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Department of Hepatopancreatobiliary Surgery, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China., Wang SJ; Department of Hepato-Biliary-Pancreatic and Vascular Surgery, The First Affiliated Hospital of Xiamen University, Xiamen, China., Weng SG; Department of Hepatopancreatobiliary Surgery, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Institute of Abdominal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Clinical Research Center for Hepatobiliary Pancreatic and Gastrointestinal Malignant Tumors Precise Treatment of Fujian Province, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Fujian Provincial Key Laboratory of Precision Medicine for Cancer, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Department of Hepatopancreatobiliary Surgery, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China., Zhang ZB; Department of Hepatopancreatobiliary Surgery, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Institute of Abdominal Surgery, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Clinical Research Center for Hepatobiliary Pancreatic and Gastrointestinal Malignant Tumors Precise Treatment of Fujian Province, the First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Fujian Provincial Key Laboratory of Precision Medicine for Cancer, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.; Department of Hepatopancreatobiliary Surgery, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, China. |
| Source: | Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2026 Jun; Vol. 46 (6), pp. e70681. |
| Publication Type: | Journal Article; Multicenter Study |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101160857 Publication Model: Print Cited Medium: Internet ISSN: 1478-3231 (Electronic) Linking ISSN: 14783223 NLM ISO Abbreviation: Liver Int Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
